Cogent Biosciences (COGT)
31.69
+0.67 (2.16%)
Upcoming Events
Latest Headlines
Cogent (COGT) Reiterated at Buy by Stifel After ASCO Presentation on Bezuclastinib
June 1, 2026 7:31 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Cogent (COGT)
June 1, 2026 6:57 AM - StreetInsider
Cogent Biosciences reports positive Phase 3 trial data for GIST treatment
May 30, 2026 8:00 AM - StreetInsider
Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clini
May 30, 2026 8:00 AM - Globe NewsWire
FDA accepts Cogent's drug application with priority review for GIST treatment
May 28, 2026 8:01 AM - StreetInsider
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST
May 28, 2026 8:00 AM - Globe NewsWire
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
May 27, 2026 8:00 AM - Globe NewsWire
Form 4 Cogent Biosciences, Inc. For: May 19 Filed by: Robbins Andrew R
May 21, 2026 4:30 PM - SEC Filing
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Flynn James E
May 14, 2026 6:21 PM - SEC Filing
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
May 12, 2026 9:30 AM - Globe NewsWire
Cogent (COGT) PT Raised to $55 at H.C. Wainwright
May 6, 2026 7:04 AM - StreetInsider
Form 10-Q Cogent Biosciences, Inc. For: Mar 31
May 5, 2026 8:22 AM - SEC Filing
Form 8-K Cogent Biosciences, Inc. For: May 05
May 5, 2026 8:08 AM - SEC Filing
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
May 5, 2026 8:00 AM - Globe NewsWire
Form ARS Cogent Biosciences, Inc. For: Dec 31
April 23, 2026 7:11 PM - SEC Filing
Form DEFA14A Cogent Biosciences, Inc.
April 23, 2026 7:11 PM - SEC Filing
Form DEF 14A Cogent Biosciences, Inc. For: Jun 09
April 23, 2026 7:11 PM - SEC Filing
Cogent Biosciences to present GIST trial data at ASCO meeting
April 21, 2026 8:01 AM - StreetInsider
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2026 8:01 AM - Globe NewsWire
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
April 17, 2026 8:00 AM - Globe NewsWire
Bernstein on US Pharma and Biotech: Who might buy whom?
April 13, 2026 5:52 AM - StreetInsider
Form 4 Cogent Biosciences, Inc. For: Apr 01 Filed by: Ferrante Karen Jean
April 3, 2026 4:01 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Cogent (COGT)
April 2, 2026 6:45 AM - StreetInsider
Cogent Biosciences submits drug application for GIST treatment
April 1, 2026 8:02 AM - StreetInsider
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
April 1, 2026 8:01 AM - Globe NewsWire
Form 144 Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
March 31, 2026 9:31 PM - SEC Filing
Form 4 Cogent Biosciences, Inc. For: Mar 31 Filed by: Fairmount Funds Management LLC
March 31, 2026 9:30 PM - SEC Filing
Form SCHEDULE 13D/A Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
March 31, 2026 9:30 PM - SEC Filing
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: VANGUARD GROUP INC
March 26, 2026 5:12 PM - SEC Filing
Jefferies says these are the best SMID-cap biotech stocks to buy
March 22, 2026 10:00 AM - StreetInsider
Raymond James Reiterates Strong Buy Rating on Cogent (COGT)
March 16, 2026 9:57 AM - StreetInsider
Jefferies Starts Cogent (COGT) at Buy
March 16, 2026 9:31 AM - StreetInsider
FDA accepts Cogent's drug application for rare blood disorder treatment
March 16, 2026 8:02 AM - StreetInsider
Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
March 16, 2026 8:00 AM - Globe NewsWire
Full Article List
